We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Senseonics Holdings Inc (SENS) USD0.001

Sell:$0.46 Buy:$0.47 Change: $0.0178 (4.03%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$0.46
Buy:$0.47
Change: $0.0178 (4.03%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$0.46
Buy:$0.47
Change: $0.0178 (4.03%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Contact details

Address:
20451 Seneca Meadows Pkwy
GERMANTOWN
20876-7005
United States
Telephone:
+1 (301) 5157260
Website:
https://www.senseonics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SENS
ISIN:
US81727U1051
Market cap:
$241.70 million
Shares in issue:
595.33 million
Sector:
Health Care Equipment
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Timothy Goodnow
    President, Chief Executive Officer, Director
  • Frederick Sullivan
    Chief Financial Officer, Treasurer, Secretary
  • Mukul Jain
    Chief Operating Officer
  • Kenneth Horton
    General Counsel, Corporate Development Advisor
  • Francine Kaufman
    Chief Medical Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.